DuoTrav® Eye Drops As Replacement Therapy Program
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of
target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for,
open-angle glaucoma (OAG) or ocular hypertension (OH).